We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis now faces competition to its top-seller Gleevec, a treatment for chronic myeloid leukemia, as Sun Pharma launched its copycat version in the U.S. Monday. Read More
The war on high pharmaceutical prices continues, with PBM Express Scripts taking aim at what it calls an excessive price jump for Valeant Pharmaceuticals’ diabetes drug Glumetza. Read More
Sharp price spikes for some orphan generics may be getting all of the attention today, but they have little real impact on overall prescription drug prices. Read More
After serving as Gilead Sciences’ CEO for 20 years, John C. Martin announced Friday that he is stepping down and will assume the role of executive chairman of the company. Read More
The UK’s healthcare cost watchdog has issued a final guidance that will reimburse seven biologicals as options for treating severe rheumatoid arthritis in patients who have not responded to conventional treatments. Read More
Tuesday’s House Oversight and Government Reform Committee hearing on drug pricing has been pushed back to Feb. 4 after a weekend blizzard buried the Washington, D.C. region in snow. Read More